Literature DB >> 19871699

STUDIES IN THE RELATION OF THE HEMOLYTIC STREPTOCOCCUS TO RHEUMATIC FEVER : III. COMPLEMENT FIXATION VERSUS STREPTOCOCCAL NUCLEOPROTEINS WITH THE SERA OF PATIENTS WITH RHEUMATIC FEVER AND OTHERS.

T N Harris1.   

Abstract

Complement-fixing antibodies to the cytoplasmic particles (CP) and to the S fraction of streptococcal nucleoproteins are present in normal human sera, the range of concentrations varying among the age groups. The titer of these antibodies rises between the first half-week and the 3rd week of scarlet fever, in more than 80 per cent of the cases. The titers then remain elevated for at least 4 months. In children, 91 per cent of the normal sera examined showed anti-CP titers up to 32; 87 per cent of sera in active rheumatic disease had titers above this level. Corresponding data with S fell in the same range of percentage distribution. Anti-CP and anti-S titers remained elevated long after the rheumatic process had reached quiescence. No correlation of serologic titer with the degree of clinical activity was found in the case of either antibody.

Entities:  

Keywords:  RHEUMATIC FEVER/relation of hemolytic streptococcus; STREPTOCOCCUS/nucleoprotein, complement fixation; STREPTOCOCCUS/rheumatic fever

Mesh:

Substances:

Year:  1948        PMID: 19871699      PMCID: PMC2135761          DOI: 10.1084/jem.87.1.57

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  1 in total

1.  STUDIES IN THE RELATION OF THE HEMOLYTIC STREPTOCOCCUS TO RHEUMATIC FEVER : II. FRACTIONATION OF THE HEMOLYTIC STREPTOCOCCUS BY HIGH SPEED CENTRIFUGATION.

Authors:  T N Harris
Journal:  J Exp Med       Date:  1948-01-01       Impact factor: 14.307

  1 in total
  1 in total

1.  Serological studies in rheumatic fever; the phase reaction and the detection of autoantibodies in the rheumatic state.

Authors:  E E FISCHEL; R H PAULI
Journal:  J Exp Med       Date:  1949-06-01       Impact factor: 14.307

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.